Volume: 8 Issue: 3
Year: 2020, Page: 56-59, Doi: https://doi.org/10.47799/pimr.0803.12
Received: Oct. 20, 2020 Accepted: Nov. 27, 2020 Published: Nov. 27, 2020
Background: Novel corona Virus disease 2019 has been declared as pandemic by WHO.It started from Wuhan, China and within less times spread has occurred through out the world .The whole world is facing a huge challenge to prevent the spread of the disease.Though there was a strong response and preventive measures taken at the onset of the pandemic but still its one of the fastest growing pandemic in India at present. Only a clear knowledge regarding the risk and complication of covid19 to the population helps in fighting out this pandemics.
Methods: A cross sectional study of 50 COVID 19 cases confirmed by Real Time Reverse Transcriptase Polymerase Chain Reaction. In the current study , prevalance and severity was assessed at 95% confidence interval. Independent statistical T test and chi- square were used to test significance( p<0.05).
Result: Out of 50 cases 20 are severe and 30 are non severe.Lymphocytopenia is one of the most important cardinal hematological feature seen in 60% of patients. It was observed in the current study that NLR & PLR was increased in severe cases.The Neutrophil to Lymphocyte ratio (NLR). is higher in severe cases (5.87±1.92) when compared to non severe cases (2.86±1.20) was statistically significant (p = 0.043). Platelet to Lymphocyte ratio (PLR) was higher in severe cases (282.08±57.85) as compared to non severe cases(216.24±36.35) and is statistically significant (p value =0.007).
Conclusion: Current study declares, Neutrophil to Lymphocyte ratio (NLR)and Platelet to Lymphocyte ratio (PLR) may be considered as good diagnostic and prognostic risk evaluators in assessing the severity and progression of the novel corona disease 2019.
Keywords: Novel Corona Disease 2019 ( Covid 19 ) . Neutrophil to Lymphocyte ratio (NLR). Platelet to Lymphocyte ratio (PLR), Real time polymerase chain reaction (RTPCR)
1. Zhang, Ting & Huang, Shaoping & Liu, Min & Li, Xiaolu & Shang, Zhiyin & Lu, Hongzhou. (2020). Significance of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio for predicting clinical outcomes in COVID-19. 10.21203/rs.3.rs-34983/v1.
2. Li X, Xu S, Yu M, Wang K, Tao Y, Zhou Y, Shi J, Zhou M, Wu B, Yang Z, et al: Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan. The Journal of allergy and clinical immunology 2020.
3. Badawi A, Ryoo SG. Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERSCoV): a systematic review and meta-analysis. Int J Infect Dis 2016; 49: 129–33.
4. Channappanavar R, Fett C, Mack M, Ten Eyck PP, Meyerholz DK, Perlman S.Sex-based differences in susceptibility to severe acute respiratory syndrome coronavirus infection. J Immunol 2017; 198: 4046–53.
5. Jaillon S, Berthenet K, Garlanda C. Sexual dimorphism in innate immunity. Clin Rev Allergy Immunol 2019; 56: 308– 21.
6. Henry BM, de Oliveira MHS, Benoit S, Plebani M, Lippi G. Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis. Clin Chem Lab Med. 2020;58(7):1021-1028.
7. Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S, Huang H, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med. 2020.
8. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020.
9. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497-506.
10. Liu Y, Du X, Chen J, Jin Y, Peng L, Wang HHX, Luo M, Chen L, Zhao Y: Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19. The Journal of infection 2020.
11. Qin C, Zhou L, Hu Z, Zhang S, Yang S, Tao Y, Xie C, Ma K, Shang K, Wang W, et al: Dysregulation of immune response in patients with COVID-19 in Wuhan, China. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America 2020.
12. Gasparyan AY, Ayvazyan L, Mukanova U, Yessirkepov M, Kitas GD. The Platelet-to-Lymphocyte Ratio as an Inflammatory Marker in Rheumatic Diseases. Annals of laboratory medicine. 2019;39(4):345–57.
13. Ha YJ, Hur J, Go DJ, Kang EH, Park JK, Lee EY, Shin K, Lee EB, Song YW, Lee YJ. Baseline peripheral blood neutrophilto-lymphocyte ratio could predict survival in patients with adult polymyositis and dermatomyositis:Aretrospective observational study. PloS one. 2018;13(1):e0190411.
14. Ying HQ, Deng QW, He BS, Pan YQ, Wang F, Sun HL, Chen J, Liu X, Wang SK. The prognostic value of preoperative NLR, d-NLR, PLR and LMR for predicting clinical outcome in surgical colorectal cancer patients. Medical oncology. 2014;31(12):305.
15. Li Q, Guan X, Wu P et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N. Engl. J. Med. 382(13), 1199–1207 (2020).
16. Lu H, Stratton CW, Tang YW. Outbreak of pneumonia of unknown etiology in Wuhan, China: the mystery and the miracle. J. Med. Virol. 92(4), 401–402 (2020).
17. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, Zhao X, Huang B, Shi W, Lu R, et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020;382(8):727–33.
18. Chang, Lin M, Wei L, Xie L, Zhu G, Dela Cruz CS, Sharma L: Epidemiologic and Clinical Characteristics of Novel Coronavirus Infections Involving 13 Patients Outside Wuhan, China. Jama 2020.
19. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, Qiu Y, Wang J, Liu Y, Wei Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507–13.
20. Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, Ren R, Leung KSM, Lau EHY, Wong JY, et al: Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. The New England journal of medicine 2020
© 2020-21 Prathima Institue of Medical Sciences
Ali SI, Farah T, Khan R, Kanyakumar M, Mohammad M, Mohammad AA. Study on Neutrophil Lymphocyte ratio and Platelet lymphocyte ratio in COVID19 from our prospective. A cross sectional study. Perspectives in Medical Research 2020; 8 (3):56-59. DOI: 10.47799/pimr.0803.12